Phase III Study on HMPL-523 for Treatment of ITP
Condition(s):Primary Immune Thrombocytopenia (ITP)Last Updated:February 8, 2023Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):Primary Immune Thrombocytopenia (ITP)Last Updated:February 8, 2023Active, not recruiting
Condition(s):Immune ThrombocytopeniaLast Updated:January 23, 2023Not yet recruiting
Condition(s):Immune Thrombocytopenic PurpuraLast Updated:October 26, 2021Unknown status
Condition(s):Immune Thrombocytopenic PurpuraLast Updated:February 14, 2014Terminated
Condition(s):Primary Immune Thrombocytopenia (ITP)Last Updated:March 26, 2024Recruiting
Condition(s):Primary Immune ThrombocytopeniaLast Updated:July 2, 2021Unknown status
Condition(s):Idiopathic Thrombocytopenic PurpuraLast Updated:January 13, 2021Completed
Condition(s):Primary Immune ThrombocytopeniaLast Updated:December 6, 2023Recruiting
Condition(s):Primary Immune ThrombocytopeniaLast Updated:March 7, 2024Completed
Condition(s):Immune Thrombocytopenia (ITP)Last Updated:September 11, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.